Piramal Enterprises Ltd (PIRA.NS) Company Profile | Reuters.com
Edition:
United States

Profile: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

1,399.70INR
6:17am EDT
Change (% chg)

Rs21.80 (+1.58%)
Prev Close
Rs1,377.90
Open
Rs1,385.00
Day's High
Rs1,426.00
Day's Low
Rs1,385.00
Volume
144,347
Avg. Vol
170,871
52-wk High
Rs1,536.00
52-wk Low
Rs804.00

Piramal Enterprises Limited, an Indian-based company is focused on pharmaceutical business, financial services and information management. The pharmaceutical segment includes Pharma Solutions, Critical Care, OTC and Ophthalmology, and Life Sciences. Pharma Solutions cover the entire drug-cycle, from development and manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. The Critical Care division offers inhalation anesthetics, such as Sevoflurane and Desflurane. OTC and Ophthalmology division includes products, such as Caladryl, Equal and Saridon. The Life Sciences division discovers and optimizes compounds in the areas, including Imaging, New Chemical Entity Research and Bio-orthopaedics. The financial services segment offers fund raising, deployment, monitoring and exit of real estate loans and investments services. The information management segment is a provider of syndicated research, information and analytics to the healthcare industry.

Company Address

Piramal Enterprises Ltd

10th floor, Piramal Tower
Ganpatrao Kadam Marg
Lower Parel
MUMBAI     400013
P: +9122.30466666
F: +9122.24902363

Company Web Links